Nav: Home

Mapping residual esophageal tumors -- a glimpse into the future?

January 10, 2019

Osaka, Japan - It's one of the first questions asked by many newly-diagnosed cancer patients--"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and available treatment options. However, post-operative testing that provides an accurate prediction of long-term treatment outcomes is the next best thing to a crystal ball, allowing clinicians to plan further treatment or follow-up strategies and more accurately inform patients about their prognoses.

But is this possible? Researchers in Japan think that it might be, at least for esophageal cancer patients. In a recent study published in Annals of Surgery, a team led by researchers at Osaka University retrospectively examined tissue specimens from 120 esophageal cancer patients following treatment, allowing them to both assess tumor characteristics and investigate how these related to long-term treatment outcomes.

Esophageal cancer is the sixth most common cause of cancer-related death worldwide and, despite various treatment options, has a poor long-term prognosis. Most locally-advanced esophageal cancers are treated with neoadjuvant chemotherapy (NAC), which aims to increase the likelihood of successful curative surgery by reducing tumor size and eradicating systemic micro-metastases. Tissue specimens are usually examined after surgery to assess how a tumor has responded to chemotherapy treatment. However, standard methods do not map the remaining tumor cells to the different layers of the esophageal wall, and therefore provide an incomplete picture of treatment outcome.

The team hypothesized that there might be specific patterns of residual tumors after NAC, and that they might have different clinical implications for patients

The researchers therefore mapped the exact locations of residual tumors in the esophageal wall of patients after NAC and assessed whether tumor location was associated with clinicopathological parameters including specific oncological outcomes.

After NAC, they identified four tumor remnant patterns that are clearly different from those reported previously; the most common residual tumor pattern was a 'shallow type.' However, in approximately 40% of cases, tumor cells unexpectedly disappeared in the superficial (mucosal) layer of the esophageal wall, indicating that it would be difficult to diagnose whether or not tumor cells completely disappeared after NAC based only on an endoscopic mucosal biopsy. When the team examined associations between these patterns and disease factors, including prognosis, they found that pattern types 3 and 4 had higher risks of pleural dissemination and distant metastases than types 1 or 2. These results shows that patients displaying patterns 3 or 4 should have more regular follow-up appointments than those with pattern types 1 or 2. Interestingly, survival was similar among the four groups.

According to lead authors Tadayoshi Hashimoto and Tomoki Makino, these findings have significant clinical implications. They explained that by determining the tumor remnant pattern from resected specimens and post-operative image examination, a personalized treatment plan for each patient can be developed. This customized approach is expected to significantly improve esophageal cancer treatment outcomes.
-end-
The article, "The pattern of residual tumor after neoadjuvant chemotherapy for locally advanced esophageal cancer and its clinical significance", was published in Annals of Surgery at doi: https://doi.org/10.1097/SLA.0000000000003129.

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan's leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan's most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university's ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: https://resou.osaka-u.ac.jp/en/top

Osaka University

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

The Emperor of All Maladies: A Biography of Cancer
by Siddhartha Mukherjee (Author)

The Truth about Cancer: What You Need to Know about Cancer's History, Treatment, and Prevention
by Ty M. Bollinger (Author)

Chris Beat Cancer: A Comprehensive Plan for Healing Naturally
by Chris Wark (Author)

The Cancer-Fighting Kitchen, Second Edition: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery
by Rebecca Katz (Author), Mat Edelson (Author)

Anticancer: A New Way of Life
by David Servan-Schreiber MD PhD (Author)

F*ck Cancer: A totally inappropriate self-affirming adult coloring book (Totally Inappropriate Series) (Volume 4)
by Jen Meyers (Author)

The Breakthrough: Immunotherapy and the Race to Cure Cancer
by Charles Graeber (Author)

The Biology of Cancer, 2nd Edition
by Robert A. Weinberg (Author)

Cancer: Step Outside the Box
by Ty M. Bollinger (Author)

The Metabolic Approach to Cancer: Integrating Deep Nutrition, the Ketogenic Diet, and Nontoxic Bio-Individualized Therapies
by Dr. Nasha Winters ND FABNO L.Ac Dipl.OM (Author), Jess Higgins Kelley MNT (Author), Kelly Turner (Foreword)

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Approaching With Kindness
We often forget to say the words "thank you." But can those two words change how you — and those around you — look at the world? This hour, TED speakers on the power of gratitude and appreciation. Guests include author AJ Jacobs, author and former baseball player Mike Robbins, Dr. Laura Trice, Professor of Management Christine Porath, and former Danish politician Özlem Cekic.
Now Playing: Science for the People

#509 Anisogamy: The Beginning of Male and Female
This week we discuss how the sperm and egg came to be, and how a difference of reproductive interest has led to sexual conflict in bed bugs. We'll be speaking with Dr. Geoff Parker, an evolutionary biologist credited with developing a theory to explain the evolution of two sexes, about anisogamy, sexual reproduction through the fusion of two different gametes: the egg and the sperm. Then we'll speak with Dr. Roberto Pereira, research scientist in urban entomology at the University of Florida, about traumatic insemination in bed bugs.